Skip to main content
PMC home page
Gut logoLink to Gut
. 1998 Aug;43(2):190–195. doi: 10.1136/gut.43.2.190

Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A gliadin

H Ellis 1, S Rosen-Bronson 1, N O'Reilly 1, P Ciclitira 1
PMCID: PMC1727224  PMID: 10189843

Abstract

Background—Future European Community regulations will require a sensitive and specific assay for measurement of coeliac toxic gluten proteins in foods marketed as gluten-free. To avoid spurious cross reactions with non-toxic proteins, specific antibodies and target antigens are required. A synthetic 19 amino acid peptide of A gliadin has been shown to cause deterioration in the morphology of small intestinal biopsy specimens of coeliac patients in remission. 
Aims—To develop an assay for detection of gluten in foods, based on measurement of a known toxic peptide. 
Methods—A monoclonal antibody raised against the toxic A gliadin peptide, with a polyclonal anti-unfractionated gliadin capture antibody, was used to develop a double sandwich enzyme linked immunosorbent assay (ELISA) for the measurement of gluten in foods. 
Results—Standard curves for gliadin and for rye, barley, and oat prolamins were produced. The sensitivity of the assay was 4 ng/ml of gliadin, 500 ng/ml for rye prolamins, and 1000 ng/ml for oat and barley prolamins. The assay could detect gluten in cooked foods, although at reduced sensitivity. Prolamins from coeliac non-toxic rice, maize, millet, and sorghum did not cross react in the assay. A variety of commercially available gluten- free foods were analysed; small quantities of gluten were detected in some products. 
Conclusion—The assay may form the basis of a sensitive method for measurement of gluten in foods for consumption by patients with coeliac disease. 



Keywords: gluten; gliadin; prolamin; coeliac disease; monoclonal antibodies

Full Text

The Full Text of this article is available as a PDF (122.4 KB).

Figure 1 .

Figure 1

Open in a new tab

Standard curve for wheat gliadin and curves for prolamins of rye, barley, and oats. 


Figure 2 .

Figure 2

Open in a new tab

Standard curves for gliadin from three varieties of wheat. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth C. C., Losowsky M. S., Walker-Smith J. A., Whitney J. D. Inter-laboratory variation in gluten detection by ELISA kit. Lancet. 1991 May 4;337(8749):1094–1094. doi: 10.1016/0140-6736(91)91739-h. [DOI] [PubMed] [Google Scholar]
  2. Ciclitira P. J., Ellis H. J., Evans D. J., Lennox E. S. Relation of antigenic structure of cereal proteins to their toxicity in coeliac patients. Br J Nutr. 1985 Jan;53(1):39–45. doi: 10.1079/bjn19850008. [DOI] [PubMed] [Google Scholar]
  3. Ciclitira P. J., Evans D. J., Fagg N. L., Lennox E. S., Dowling R. H. Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) 1984 Mar;66(3):357–364. doi: 10.1042/cs0660357. [DOI] [PubMed] [Google Scholar]
  4. Ellis H. J., Doyle A. P., Wieser H., Sturgess R. P., Ciclitira P. J. Specificities of monoclonal antibodies to domain I of alpha-gliadins. Scand J Gastroenterol. 1993 Mar;28(3):212–216. doi: 10.3109/00365529309096074. [DOI] [PubMed] [Google Scholar]
  5. Ellis H. J., Doyle A. P., Wieser H., Sturgess R. P., Day P., Ciclitira P. J. Measurement of gluten using a monoclonal antibody to a sequenced peptide of alpha-gliadin from the coeliac-activating domain I. J Biochem Biophys Methods. 1994 Jan;28(1):77–82. doi: 10.1016/0165-022x(94)90066-3. [DOI] [PubMed] [Google Scholar]
  6. Friis S. U. Enzyme-linked immunosorbent assay for quantitation of cereal proteins toxic in coeliac disease. Clin Chim Acta. 1988 Dec 30;178(3):261–270. doi: 10.1016/0009-8981(88)90234-3. [DOI] [PubMed] [Google Scholar]
  7. Holmes G. K., Prior P., Lane M. R., Pope D., Allan R. N. Malignancy in coeliac disease--effect of a gluten free diet. Gut. 1989 Mar;30(3):333–338. doi: 10.1136/gut.30.3.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Howdle P. D., Losowsky M. S. Review of methods for measuring gliadins in food. Gut. 1990 Jun;31(6):712–713. doi: 10.1136/gut.31.6.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Janatuinen E. K., Pikkarainen P. H., Kemppainen T. A., Kosma V. M., Järvinen R. M., Uusitupa M. I., Julkunen R. J. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med. 1995 Oct 19;333(16):1033–1037. doi: 10.1056/NEJM199510193331602. [DOI] [PubMed] [Google Scholar]
  10. Johansen B. H., Gjertsen H. A., Vartdal F., Buus S., Thorsby E., Lundin K. E., Sollid L. M. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin Immunol Immunopathol. 1996 Jun;79(3):288–293. doi: 10.1006/clin.1996.0081. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Shidrawi R. G., Parnell N. D., Ciclitira P. J., Travers P., Evan G., Rosen-Bronson S. Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay. Clin Exp Immunol. 1998 Jan;111(1):158–165. doi: 10.1046/j.1365-2249.1998.00448.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Skerritt J. H., Hill A. S. Enzyme immunoassay for determination of gluten in foods: collaborative study. J Assoc Off Anal Chem. 1991 Mar-Apr;74(2):257–264. [PubMed] [Google Scholar]
  14. Skerritt J. H., Hill A. S. Self-management of dietary compliance in coeliac disease by means of ELISA "home test" to detect gluten. Lancet. 1991 Feb 16;337(8738):379–382. doi: 10.1016/0140-6736(91)91163-o. [DOI] [PubMed] [Google Scholar]
  15. Sturgess R., Day P., Ellis H. J., Lundin K. E., Gjertsen H. A., Kontakou M., Ciclitira P. J. Wheat peptide challenge in coeliac disease. Lancet. 1994 Mar 26;343(8900):758–761. doi: 10.1016/s0140-6736(94)91837-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES